|
gptkbp:instanceOf
|
Controlled substance category
|
|
gptkbp:abusePotential
|
Moderate to low
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:criteria
|
Abuse may lead to moderate or low physical dependence or high psychological dependence
Currently accepted medical use in treatment in the United States
Potential for abuse less than Schedule I and II
|
|
gptkbp:definedIn
|
gptkb:Controlled_Substances_Act
|
|
gptkbp:example
|
gptkb:Anabolic_steroids
gptkb:Buprenorphine
gptkb:Ketamine
gptkb:Testosterone
gptkb:Tylenol_with_codeine
Dronabinol
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schedule III drugs
|
|
gptkbp:legalStatus
|
Prescription only
|
|
gptkbp:lowerAward
|
gptkb:Schedule_II_drugs
|
|
gptkbp:medicalUse
|
gptkb:Accepted
|
|
gptkbp:prescriptionRefillsAllowed
|
Up to 5 times in 6 months
|
|
gptkbp:rank
|
gptkb:Schedule_IV_drugs
|
|
gptkbp:regulates
|
gptkb:United_States_Drug_Enforcement_Administration
|
|
gptkbp:scheduleLevel
|
III
|
|
gptkbp:traffickingPenalty
|
Less severe than Schedule I or II
|
|
gptkbp:bfsParent
|
gptkb:Title_II:_Controlled_Substances_Act
gptkb:Controlled_Substances_Act_(US)
|
|
gptkbp:bfsLayer
|
7
|